Corona Remedies News and Updates

Name: Latest research reports of Corona Remedies Ltd. authored by HDFC Securities and published by - Trendlyne research reports.
Item: Corona Remedies Ltd.
Rating: 3
Author: HDFC Securities

Keep track of all breaking news on Corona Remedies from all sources in a single place.

Corona Remedies Ltd.

08 Dec 2025, 09:53AM

IPO Note - Corona Remedies Limited - 08122025

Corona Remedies Ltd.

HDFC Securities

IPO Note - Corona Remedies Limited Corona Remedies Limited is an India-focused branded pharma firm, develops, manufactures, and markets 71 brands across women's healthcare, cardio-diabeto, pain management, urology, and more

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

Corona Remedies Ltd.

08 Dec 2025, 12:00AM

CORONA REMEDIES LIMITED

Corona Remedies Ltd.

Hem Securities

formulation company engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. Company is the fastest growing company among the top 30 companies in the Indian Pharmaceutical Market (IPM) in terms of domestic sales in the IPM, between MAT June 2024 and MAT June 2025. During this period, company's domestic sales grew at a CAGR of 13.58% compared to the IPM which grew at a CAGR of...

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

Corona Remedies Ltd.

08 Dec 2025, 12:00AM

IPO Note

Corona Remedies Ltd.

Deven Choksey

The company has undertaken recent acquisitions like Myoril from Sanofi and Spye from Bayer. It is bolstering its gynaecology and cardiology portfolio and executed a partnership with Ferring for Solifenacin.

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

Corona Remedies Ltd.

05 Dec 2025

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Business Standard

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at 1,427, commanding a grey market premium of 365 or 34.4 per cent on Friday

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

From 5 lakh start-up to a pharma powerhouse of Gujarat: The Corona Remedies Story

Business Line | 04 Dec 2025

Corona Remedies Ltd.

05 Dec 2025

CORONA REMEDIES LTD.

Corona Remedies Ltd.

Ventura

IPO NOTE

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

Corona Remedies Ltd.

05 Dec 2025

Corona Remedies: IPO

Corona Remedies Ltd.

ICICI Direct

The company owns installed capacity for wide range of dosage and packaging forms, such as tablets, capsules (including hard and soft gelatines), sachets, liquids and drops, with a total of 11 production lines...

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.

Corona Remedies Ltd.

04 Dec 2025

Corona Remedies Ltd IPO Note

Corona Remedies Ltd.

SBI Securities

Corona Remedies Ltd (Corona) is an India-focused domestic branded formulations company engaged in the development, manufacturing & marketing of products in the women's health, cardio-diabeto, pain management, urology, etc therapies. The company's diversified product portfolio comprises of 71 brands, including 27 engine brands as of Jun'25. On MAT Jun'25 basis, Corona was the 29th largest pharmaceutical company in India and positioned as the 17th largest company in its covered...

HDFC Securities released a IPO Note report for Corona Remedies Ltd. on 08 Dec, 2025.